Once‐Daily Intravenous Cefazolin Plus Oral Probenecid Is Equivalent to Once‐Daily Intravenous Ceftriaxone Plus Oral Placebo for the Treatment of Moderate‐to‐Severe Cellulitis in Adults
Open Access
- 1 June 2002
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 34 (11) , 1440-1448
- https://doi.org/10.1086/340056
Abstract
A once-daily regimen of cefazolin (2 g intravenously [iv]) plus probenecid (1 g by mouth) was compared with a once-daily regimen of ceftriaxone (1 gKeywords
This publication has 15 references indexed in Scilit:
- PHARMACOKINETICS AND PHARMACODYNAMICS OF OUTPATIENT INTRAVENOUS ANTIMICROBIAL THERAPYInfectious Disease Clinics of North America, 1998
- Home‐based treatment of cellulitis with twice‐daily cefazolinThe Medical Journal of Australia, 1998
- Association of Athlete's Foot with Cellulitis of the Lower Extremities: Diagnostic Value of Bacterial Cultures of Ipsilateral Interdigital Space SamplesClinical Infectious Diseases, 1996
- Ceftriaxone versus cefazolin with probenecid for severe skin and soft tissue infectionsThe Journal of Emergency Medicine, 1996
- Current and future management of serious skin and skin-structure infectionsThe American Journal of Medicine, 1996
- Randomized Comparison Trial of Teicoplanin IV, Teicoplanin IM, and Cefazolin Therapy for Skin and Soft Tissue Infections Caused by Gram-Positive BacteriaSouthern Medical Journal, 1994
- CellulitisHospital Practice, 1993
- Once-daily ceftriaxone for skin and soft tissue infectionsAntimicrobial Agents and Chemotherapy, 1985
- Approaches to sample size estimation in the design of clinical trials—a reviewStatistics in Medicine, 1984
- Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settingsAntimicrobial Agents and Chemotherapy, 1983